ArticleJournal of neuro-oncology2020

Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.

H Pinson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.